Certainly! Here's a more detailed product information outline for FITC anti-human CD41/CD61:

---

Product Name: FITC Anti-Human CD41/CD61

Product Description:
FITC Anti-Human CD41/CD61 is a fluorescent conjugated antibody used for the identification and analysis of CD41/CD61 antigens on human platelets. CD41, also known as integrin alpha-IIb, and CD61, known as integrin beta-3, are components of the platelet glycoprotein IIb/IIIa complex which plays a crucial role in platelet aggregation and thrombus formation. This antibody is conjugated with fluorescein isothiocyanate (FITC), allowing for direct detection and analysis using flow cytometry or fluorescence microscopy.

Key Features:
- Specificity: High specificity for human CD41/CD61 antigens.
- Conjugation: FITC provides bright fluorescence for easy detection.
- Quality: Stringently tested to ensure reliable performance.
- Versatility: Suitable for various applications including flow cytometry and immunofluorescence.

Storage:
- Temperature: Store at 2-8°C.
- Protection: Keep away from light to prevent degradation of the FITC conjugate.
- Stability: The product is stable for up to one year when stored properly.

What's Included:
- FITC Anti-Human CD41/CD61 antibody, provided in a buffer solution to maintain antibody stability.
- Certificate of Analysis for product validation and quality assurance.
- User guide with protocol recommendations for optimal results.

Applications:
- Flow Cytometry: Ideal for the identification and quantification of CD41/CD61 expressing cells in mixed populations.
- Immunofluorescence Microscopy: Suitable for visualizing the localization of CD41/CD61 on platelets and other relevant cell types.
- Research Applications: Useful in studies related to platelet function, coagulation, and cardiovascular diseases.
- Clinical Research: May be used in the investigation of platelet-related disorders and monitoring therapeutic interventions.

---

This template ensures comprehensive coverage of the product’s features and usage, providing users with the necessary information to effectively utilize the FITC anti-human CD41/CD61 antibody in their research.